A Phase 2 Study to Evaluate Safety and Efficacy of EB-001 Injections in Facial Scar Reduction After Undergoing Mohs Surgery
Phase of Trial: Phase II
Latest Information Update: 09 Jan 2019
At a glance
- Drugs Botulinum toxin E (Primary)
- Indications Scars
- Focus Proof of concept; Therapeutic Use
- Acronyms SHINE-1
- Sponsors Bonti
- 02 Aug 2018 According to a Bonti media release, status changed from recruiting to completed.
- 02 Aug 2018 Results presented in a Bonti media release.
- 09 Jul 2018 Planned primary completion date changed from 31 May 2018 to 31 Jul 2018.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History